(ad)

Investigational New Drug (IND) Update – Sickle Cell Disease

This week’s IND update looks at two distinct gene-editing strategies for sickle cell disease from Graphite Bio and Editas Medicine, both of which are set to enter clinical trials soon following the green light from the American Food and Drug Administration (FDA). Read the update right here.

Career CRISPR Medicine

• Freelancer | CRISPR Medicine News - Anyplace

Thank you for now - more great reads are on the way!

And if you have questions or suggestions, you can reach out to us directly at editor@crisprmedicinenews.com. We love hearing from readers!

Happy Reading!

Karen

p.s. You can follow CRISPR Medicine News on Twitter and LinkedIn. If someone forwarded this email to you, you can sign up for our newsletter yourself here.

(ad)

CRISPR QC pioneers streamlined and automated CRISPR quality control tools to accelerate research while improving accuracy and performance.

(ad)

Call for Papers: Frontiers in Genome Editing Open for submissions: Abstract Deadline: 1st February 2021 Final Manuscript Deadline: 2nd May 2021